---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-018009"
form_type: "8-K"
ticker: "ERNA"
cik: "0000748592"
company_name: "Ernexa Therapeutics Inc."
filed_at: "2025-07-07T23:59:59+00:00"
generated_at: "2026-05-18T09:23:44.162897+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Ernexa Therapeutics dismisses Grant Thornton, appoints Haskell & White as auditor

## Summary
- Dismissal of Grant Thornton effective June 30, 2025; appointment of Haskell & White effective July 1, 2025, approved by Audit Committee.
- Grant Thornton's reports for FY 2023 and 2024 included a going-concern explanatory paragraph but were otherwise unqualified.
- No disagreements with Grant Thornton; only disclosed material weakness in FY 2023 internal controls from lack of technical accounting proficiency.
- Grant Thornton provided a letter to the SEC regarding the dismissal, attached as Exhibit 16.1.

## SEC filing metadata
- accession: 0001641172-25-018009
- form_type: 8-K
- ticker: ERNA
- cik: 0000748592
- company_name: Ernexa Therapeutics Inc.
- filed_at: 2025-07-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 4.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/748592/000164117225018009/0001641172-25-018009-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/748592/000164117225018009/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-018009
- JSON: https://secwatch.observer/filing/0001641172-25-018009.json
- Plain text: https://secwatch.observer/filing/0001641172-25-018009.txt

## Key facts
- Auditor Changes
  Ernexa Therapeutics Inc. dismissed Grant Thornton LLP as its auditor.
  - Action: dismissal
  - Auditor: Grant Thornton LLP
  source text: ismissal of Former Independent Registered Public Accounting Firm On June 30, 2025, Ernexa Therapeutics Inc. (the “Company) dismissed Grant Thornton LLP (“Grant Thornton”) as the Company’s independent registered public accounting firm effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/748592/000164117225018009/0001641172-25-018009-index.htm
- Auditor Changes
  Ernexa Therapeutics Inc. engaged Haskell & White LLP as its auditor.
  - Action: engagement
  - Auditor: Haskell & White LLP
  source text: he statements made by the Company in this Item 4.01 insofar as they relate to Grant Thornton’s audit services and engagement as the Company’s independent registered public accounting firm. Grant Thornton has furnished a letter addressed to the SEC, a copy of which is attached hereto as Exhibit 16.1. (b) Appointment of New Independent Registered Public Accounting Firm On July 1, 2025, the Company engaged Haskell & White LLP (“Haskell & White”) as the Company’s independent registered
  evidence_url: https://www.sec.gov/Archives/edgar/data/748592/000164117225018009/0001641172-25-018009-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.